Shares of Tilray fell by a staggering 32.55% in 30 days from $23.87 to $16.10 at 21:05 EST on Tuesday, after three successive sessions in a row of losses. NASDAQ Composite is falling 1.88% to $13,633.50, after three successive sessions in a row of losses.
Tilray’s last close was $17.02, 316.15% below its 52-week high of $67.00.
Tilray’s sales growth is 18.7% for the ongoing quarter and 21.8% for the next. The company’s growth estimates for the current quarter and the next is 94.2% and 87.7%, respectively.
Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 191.34M for the twelve trailing months.
Tilray’s Stock Yearly Top and Bottom Value
Tilray’s stock is valued at $16.10 at 21:05 EST, way under its 52-week high of $67.00 and way higher than its 52-week low of $4.41.
Tilray’s Moving Average
Tilray’s worth is way under its 50-day moving average of $25.35 and way higher than its 200-day moving average of $14.55.
Previous days news about Tilray
Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue. According to MarketWatch on Sunday, 2 May, " Under the terms of the proposed deal, Aphria shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria share owned. "
Tilray says shares will start trading on toronto stock exchange from May 5 after Aphria merger approved. According to MarketWatch on Monday, 3 May, "Canadian cannabis company Tilray Inc. said Monday its shares will continue to trade on Nasdaq under the ticker symbol "TLRY" after its merger with fellow Canadian cannabis company Aphria Inc. which shareholders approved on Friday, and will start to trade on the Toronto Stock Exchange under the same ticker from May 5. "
More news about Tilray.